Optiver Holding
TYRA icon

Optiver Holding’s Tyra Biosciences TYRA Stock Holding History

Optiver Holding’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13K Sell
98
-8
-8% -$265 ﹤0.01% 2157
2026
Q1 		$4.06K Sell
106
-22
-17% -$712 ﹤0.01% 1517
2025
Q4 		$3.37K Sell
128
-240
-65% -$4.41K ﹤0.01% 1676
2025
Q3 		$5.15K Buy
+368
New +$4.2K ﹤0.01% 1715

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Optiver Holding's TYRA Position: Q2 2026 in Review

Optiver Holding reduced its Tyra Biosciences (TYRA) stake by 7.5% in Q2 2026, selling an estimated $265 and leaving 98 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

Optiver Holding first reported a position in TYRA in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.15K in Q3 2025. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Optiver Holding held 98 shares of Tyra Biosciences worth $3.13K as of Q2 2026.
  • Optiver Holding sold 8 Tyra Biosciences shares in Q2 2026, an estimated $265.
  • Tyra Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2157 holding.
  • Optiver Holding first reported a position in Tyra Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Tyra Biosciences position peaked at $5.15K in Q3 2025.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.